SMC and RTS,S vaccine in combination show considerable advantage in preventing malaria

MMV launches call for compounds to accelerate research into new drugs for malaria

New predictive models to support optimal antimalarial use now openly available

Brazil becomes the first malaria-endemic country to register single-dose tafenoquine for children with relapsing malaria

MMV receives rank of “very high performer” in 2023 Global Health 50/50 report for 2nd year

MMV deeply saddened by the loss of Kamran Rafiq

MMV presents Fosun Pharma with an award for their commitment to global health

MMV awards Dr Stephen Brand-led team for developing innovative dose prediction tool 'MMVSola'

Brazil becomes the first malaria-endemic country to adopt single-dose tafenoquine and STANDARD G6PD Test for the treatment of relapsing Plasmodium vivax malaria

MMV delivers statements at 76th World Health Assembly

Changing of the guard at the RBM Partnership to End Malaria

MMV echoes Swiss Malaria Group's call to invest and innovate to end malaria

MMV mourns the loss of Pascoal Mocumbi, former Mozambican prime minister and EDCTP High Representative

MMV welcomes appointment of Dr Daniel Ngamije as Director of Global Malaria Control Programme

MMV’s film on real-world tafenoquine study wins advocacy award at the 7th annual ISNTD festival

MMV ESAC member Dennis Smith recognized by the International Society for the Study of Xenobiotics

46 million reasons and more to celebrate

Medicines for Malaria Venture and the Africa CDC sign Memorandum of Understanding to support African manufacturers

Holding the line against malaria in 2021 despite ongoing challenges

WHO gives ‘strong recommendation’ supporting use of antimalarial drug to treat pregnant women in the first trimester

Strong recommendation for pyronaridine-artesunate in revised WHO Malaria Treatment Guidelines

Novartis and Medicines for Malaria Venture announce decision to move to Phase 3 study for novel ganaplacide/lumefantrine-SDF combination in adults and children with malaria

RBM Malaria in Pregnancy Working Group meeting in Accra